Nasus Pharma Ltd (NSRX) Operating cash flow 2023–2025
Nasus Pharma Ltd (NSRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.9MFY2025 · since FY2023: -$1.0M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | -639.5% |
| FY2024 | -$665,000 | +35.4% |
| FY2023 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NSRX financial trends
NSRX RevenueNSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating incomeNSRX Operating marginNSRX Free cash flowNSRX Capital expendituresNSRX Return on equityNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Total liabilitiesNSRX Shareholders’ equityNSRX overview →